What is Nephro-Tech?
Nephro-Tech, Inc., established in 1992, is a dedicated provider of high-quality pharmaceuticals and dietary supplements tailored for dialysis patients. The company's product portfolio features essential items such as prescription iron supplements and specialized renal vitamins, formulated to address nutrient depletion common during dialysis treatments. Nephro-Tech's core mission revolves around delivering cost-effective and convenient solutions to healthcare providers and individuals navigating the challenges of chronic kidney disease, emphasizing accessibility and affordability in its offerings.
How much funding has Nephro-Tech raised?
Nephro-Tech has raised a total of $79K across 1 funding round:
Debt
$79K
Debt (2021): $79K with participation from PPP
Key Investors in Nephro-Tech
PPP
Public-Private Partnership
What's next for Nephro-Tech?
With significant Series B/C stage backing, Nephro-Tech is poised for accelerated growth and market penetration. The recent substantial expansion capital injection suggests a strategic focus on scaling operations, potentially through enhanced product development, broader distribution networks, or further research into renal patient care. This investment signals investor confidence in Nephro-Tech's business model and its capacity to address a critical unmet need in the healthcare sector, paving the way for enhanced patient outcomes and sustained company development.
See full Nephro-Tech company page
